In allergen-driven models of atopic dermatitis, subcutaneous (SQ) administration of ‘1104 demonstrated comparable performance to intravenous administration (IV)In multiple preclinical...
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy...
PALO ALTO, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative...
Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner...
Data shows strong overall survival, progression-free survival, and durability from novel combination of efti in combination with pembrolizumab in difficult-to-treat...
The south suburban Chicago home-like facility is expected to serve 500+ patients each yearCHICAGO, Dec. 12, 2024 (GLOBE NEWSWIRE) --...
A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med with...
Precede Bio’s ER dependency index (PERDI) tests for both ER dependent and ER independent mechanisms of cancer growth, addressing an...
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
- IMM-1-104 has the potential to benefit melanoma patients who have progressed on or are intolerant to immune checkpoint inhibitors...
Has helped over 24,400 Seniors Age Safely at Home Since Its InceptionDENVER, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding...
DALLAS, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven...
Clear evidence of SERPINA1 gene delivery and AAT expression following KB408 administration in AATD patients Both KB408 for AATD patients...
Webcast on December 17 at 8:00 AM EST to feature ALX Oncology leadership and study principal investigator Alberto J. Montero,...
CTO Role to Focus on Growth from New Market and Revenue StrategiesLAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) --...
Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical...
Driving early drug discovery from gene to leadStrengthening collaborations and accessibility across North America Milan, Italy & Cambridge, MA, USA...
Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in HorsesToronto, Ontario and Philadelphia, Pennsylvania--(Newsfile Corp....
HANGZHOU, China, Dec. 12, 2024 /PRNewswire/ -- The ceremony for the 2024 Design Intelligence Award (DIA) took place on December...